These Healthcare stocks are trading higher:
-Neximmune Inc (NEXI) stock is trading at $21.94, an increase of $12.64, or 138.01%, on high volume. Neximmune Inc gets a Sentiment Score of Bullish from InvestorsObserver. Neximmune Inc next reports earnings on February 15.
-PepGen Inc (PEPG) stock is trading at $10.75, an increase of $3.5, or 46.9%, on high volume. Pepgen Inc gets a Sentiment Score of Very Bullish from InvestorsObserver and receives an average analyst recommendation of Strong Buy with a price target of $22.80. Pepgen Inc next reports earnings on February 6.
-Vivos Therapeutics Inc (VVOS) stock is trading at $8.28, a gain of $1.67, or 23.49%, on high volume. Vivos Therapeutics Inc gets a Sentiment Score of Bullish from InvestorsObserver. Vivos Therapeutics Inc next reports earnings on February 12.
-Aclarion Inc (ACON) stock is trading at $2.92, a gain of $0.42, or 16.37%, on low volume. Aclarion Inc gets a Sentiment Score of Bearish from InvestorsObserver and receives an average analyst recommendation of Strong Buy with a price target of $48.02. Aclarion Inc next reports earnings on February 13.
Find the top stocks in the Healthcare Sector here.
These Healthcare stocks are trading lower:
-Nyxoah SA (NYXH) stock is trading at $7.93, a loss of $4.41, or 35.74%, on high volume. Nyxoah S A gets a Sentiment Score of Very Bullish from InvestorsObserver and receives an average analyst recommendation of Strong Buy with a price target of $11.40. Nyxoah S A next reports earnings on February 6.
-Revelation Biosciences Inc (REVB) stock is trading at $8.55, a decline of $4.44, or 34.18%, on high volume. Revelation Biosciences Inc gets a Sentiment Score of Bullish from InvestorsObserver and receives an average analyst recommendation of Strong Buy with a price target of $343.84. Revelation Biosciences Inc next reports earnings on February 7.
-Aileron Therapeutics Inc (ALRN) stock is trading at $4.61, a loss of $1.33, or 22.55%, on low volume. Aileron Therapeutics Inc gets a Sentiment Score of Very Bullish from InvestorsObserver and receives an average analyst recommendation of Strong Buy with a price target of $9.00.
-Avrobio Inc (AVRO) stock is trading at $1.14, a decline of $0.24, or 17.52%, on high volume. Avrobio Inc gets a Sentiment Score of Bullish from InvestorsObserver and receives an average analyst recommendation of Strong Buy with a price target of $3.50. Avrobio Inc next reports earnings on February 7.
Find the top stocks in the Healthcare Sector here.